AJR Women's Imaging Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow CME/SAM
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, C.-H.
Right arrow Articles by Beaty, S. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, C.-H.
Right arrow Articles by Beaty, S. D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
DOI:10.2214/AJR.07.7076
AJR 2008; 190:S65-S68
© American Roentgen Ray Society


AJR Integrative Imaging LIFELONG LEARNING FOR RADIOLOGY

Imaging of Focal Hepatic Lesions: Self-Assessment Module

Chang-Hsien Liu1, Douglas C. Rivard2, Alvin C. Silva3, Kimberly J. Burkholz3 and Sean D. Beaty3

1 Division of Abdominal Imaging and Interventional Radiology, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
2 Department of Radiology, Children's Mercy Hospitals and Clinics and the University of Missouri-Kansas City, Kansas City, MO.
3 Department of Diagnostic Radiology, Mayo Clinic, 13400 E Shea Blvd., Scottsdale, AZ.

Received January 28, 2008; accepted after revision January 29, 2008.

Address correspondence to A. C. Silva (silva.alvin{at}mayo.edu).

Abstract

Focal hepatic lesions are one of the diagnostic challenges in daily practice. This article focuses on the imaging features of focal hepatic lesions on different imaging modalities, including sonography, CT, and MRI.

Keywords: focal hepatic lesions • hemangiomatosis • hepatoblastoma • Staphylococcus aureus

INTRODUCTION

This self-assessment module on imaging of focal hepatic lesions has an educational component and a self-assessment component. The educational component consists of four required articles that the participant should read. An additional article is recommended. The self-assessment component consists of 12 multiple-choice questions with solutions. All of these materials are available on the ARRS Web site (www.arrs.org). To claim CME and SAM credit, each participant must enter his or her responses to the questions online.

EDUCATIONAL OBJECTIVES

By completing this educational activity, the participant will:

  1. Exercise, self-assess, and improve his or her understanding of imaging features of focal hepatic lesions on different radiologic techniques.
  2. Exercise, self-assess, and improve his or her understanding of the role of imaging in the clinical management of patients with focal hepatic lesions.

REQUIRED READING

  1. Rivard DC, Lowe LH. Radiological reasoning: multiple hepatic masses in an infant. AJR 2008;190 [suppl]:S46–S52[Free Full Text]
  2. Liu CH, Yu CY, Catalano OA, Mueller PR. Radiological reasoning: imaging differentiation of a solitary hepatic mass. AJR 2008;190 [suppl]:S57–S61[Free Full Text]
  3. Beaty SD, Silva AC, DePetris G. AJR teaching file: incidental hepatic mass. AJR 2008;190 [suppl]:S62–S64[Free Full Text]
  4. Burkholz KJ, Silva AC. AJR teaching file: hypervascular metastasis or hepatic hemangioma? AJR2008 ;190 [suppl]:S53–S56[Free Full Text]

RECOMMENDED READING

  1. Bittle MM, Chew FS. Radiological reasoning: incidentally discovered liver mass. AJR 2006;186 [6 suppl 1]:S434 –S441[Abstract/Free Full Text]

INSTRUCTIONS

  1. Complete the required reading.
  2. Visit www.arrs.org and select Publications/Journals/SAM articles from the left-hand menu bar.
  3. Using your member login, order the online SAM as directed.
  4. Follow the online instructions for entering your responses to the self-assessment questions and complete the test by answering the questions online.


QUESTION 1

In children, which is the most common hepatic malignancy?

  1. Metastatic Wilms' tumor.
  2. Angiosarcoma.
  3. Hepatoblastoma.
  4. Hemangioendothelioma.
  5. Metastatic neuroblastoma.

QUESTION 2

In children with pyogenic hepatic abscesses, which is the most common causative organism?

  1. Klebsiella pneumoniae.
  2. Staphylococcus aureus.
  3. Bacteroides fragilis.
  4. Bartonella henselae.
  5. Escherichia coli.

QUESTION 3

In infants with negative serum catecholamines and low {alpha}-fetoprotein levels and multiple hyperechoic hepatic lesions on sonography, which would be the most common condition?

  1. Metastatic neuroblastoma.
  2. Angiosarcoma.
  3. Hepatoblastoma.
  4. Leukemia.
  5. Hemangiomatosis.

QUESTION 4

For a patient with hepatic hemangiomatosis documented by sonography, which would be the most appropriate additional imaging workup?

  1. None necessary.
  2. Percutaneous biopsy.
  3. MRI with gadolinium.
  4. Invasive angiography.
  5. Tagged RBC nuclear scanning.

QUESTION 5

On sonography, which hepatic lesion is most typically hyperechoic?

  1. Hepatocellular carcinoma.
  2. Hepatocellular adenoma.
  3. Small hemangioma.
  4. Peripheral cholangiocarcinoma.
  5. Inflammatory pseudotumor.

 


QUESTION 6

In patients with a focal liver lesion, which MRI feature most strongly suggests inflammatory pseudotumor?

  1. Peripheral parenchymal edema with delayed enhancement.
  2. Globular discontinuous peripheral enhancement on arterial phase images.
  3. Hyperintensity of the mass lesion on T1-weighted images.
  4. Marked light-bulb-like hyperintensity on T2-weighted images.
  5. Enhanced central scar in delayed phase images.

QUESTION 7

On MRI of the liver, all of the following lesions show delayed enhancement EXCEPT:

  1. Hemangioma.
  2. Peripheral cholangiocarcinoma.
  3. Inflammatory pseudotumor.
  4. Hepatocellular carcinoma.

QUESTION 8

On MRI of the liver, which of the following is hyperintense on T2-weighted images?

  1. Calcification.
  2. Hemosiderin deposition.
  3. Fibrosis.
  4. Uncomplicated cyst fluid.
  5. High-flow arteriovenous malformation.

QUESTION 9

In patients with chronic hepatitis C who develop primary hepatic lymphoma, which is the most common cellular type?

  1. T-cell non-Hodgkin's lymphoma.
  2. B-cell non-Hodgkin's lymphoma.
  3. Nodular sclerosing Hodgkin's lymphoma.
  4. Mixed-cellularity Hodgkin's lymphoma.
  5. Lymphocyte-rich Hodgkin's lymphoma.

 


QUESTION 10

On contrast-enhanced CT of the liver, which of the following best describes "peripheral washout?"

  1. Peripheral hypervascular enhancement on arterial phase images.
  2. Homogeneous hypervascular enhancement on arterial phase images.
  3. Peripheral hypovascular enhancement on portal phase images.
  4. Central hypovascularity on delayed phase images.
  5. Peripheral hypovascularity on delayed phase images.

QUESTION 11

On contrast-enhanced CT of the liver, which enhancement pattern indicates hemangioma?

  1. Early: homogeneous hyperenhancement; delayed: hypoenhancement.
  2. Early: homogeneous hyperenhancement; delayed: isoenhancement.
  3. Early: homogeneous hyperenhancement; delayed: hyperenhancement.
  4. Early: heterogeneous hyperenhancement; delayed: hyperenhancement.
  5. Early: heterogeneous hypoenhancement; delayed: hypoenhancement.

QUESTION 12

In patients who have received chemotherapy for hepatic metastases, which imaging feature is most useful in distinguishing treated metastases from hemangioma?

  1. Arterial phase hyperenhancement.
  2. Contrast retention on portal venous or delayed phase.
  3. T2-weighted hyperintensity.
  4. Continuous peripheral nodular enhancement.
  5. T1-weighted hypointensity.

 

Solution to Question 1
Hepatoblastoma is the most common hepatic malignancy in children [1, 2]. Option C is the best response. Metastatic Wilms' tumor, angiosarcoma, hemangioendothelioma, and metastatic neuroblastoma are less common then hepatoblastoma in this age group. Options A, B, D, and E are not the best responses.

Solution to Question 2
Although all of the listed bacteria may be potential causes of pyogenic liver abscesses, most literature recognizes Staphylococcus aureus as the most common isolated organism [3]. Option B is the best response. Options A, C, D, and E are not the best responses.

Solution to Question 3
Because of the negative serum markers, hemangiomatosis would be the lesion that would most commonly cause multiple hyperechoic hepatic lesions. Option E is the best response. Although the described lesions can be seen with metastatic neuroblastoma tumor, the negative serum markers allow confident exclusion of this disease [4]. Option A is not the best response. Hepatoblastoma is excluded by a normal {alpha}-fetoprotein level. Option C is not the best response. The remaining entities, angiosarcoma and leukemia, are much less common than multiple hemangiomas in infants [5]. Options B and D are not the best responses.

Solution to Question 4
Hepatic hemangiomas typically undergo an initial proliferative phase followed by regression and gradual involution [6]. Therefore, no additional imaging is required once the diagnosis is made [7]. Option A is the best response. Options B, C, D, and E are not the best responses because additional imaging workup is not appropriate in this circumstance.

Solution to Question 5
Hepatocellular carcinoma and hepatocellular adenoma show variable echogenicity on sonography [8]. Options A and B are not the best responses. Peripheral cholangiocarcinoma and inflammatory pseudotumor usually appear as hypoechoic masses on sonography [8, 9]. Options D and E are not the best responses. Small hemangiomas most typically appear on sonography as hyperechoic lesions. Option C is the best response.

Solution to Question 6
Inflammatory pseudotumors are composed of fibrous tissue associated with mixed inflammatory cells and areas of necrosis. The marked fibrosis could be responsible for the hypovascular appearance, with hypointensity on T1-weighted images, mild hyperintensity on T2-weighted images, and late enhancement after contrast material administration [10]. Option A is the best response. The other MRI features are not characteristic of inflammatory pseudotumor. Options B, C, D, and E are not the best responses.

Solution to Question 7
Hemangiomas appear as typical enhancement characteristics of nodular enhancement in the arterial phase images, followed by gradual centripetal filling-in in the delayed phase images [8]. Option A is not the best response. Peripheral cholangiocarcinoma and inflammatory pseudotumor show a hypovascular appearance with late enhancement after contrast material administration [8, 10]. Options B and C are not the best responses. Hepatocellular carcinomas typically show enhancement in the arterial phase images and rapid contrast washout in the portal venous phase images [8]. Hepatocellular carcinomas do not show delayed enhancement; therefore Option D is the best response.

Solution to Question 8
Uncomplicated cyst fluid is hyperintense on T2-weighted MR images. Option D is the best response. Hemosiderin deposition, calcification, and fibrosis show hypointensity on T2-weighted MR images. Options A, B, and C are not the best responses. Arteriovenous malformation with high flow also appears hypointense on T2-weighted MR images due to flow void [11]. Option E is not the best response.

Solution to Question 9
Although both Hodgkin's and non-Hodgkin's lymphoma (NHL) can secondarily involve the liver, most primary hepatic lymphomas are due to B-cell NHL. A recent meta-analysis revealed an increased prevalence of hepatitis C virus infection in patients with B-cell NHL, compared with both the general population and patients with other types of hematologic malignancies [12]. Option B is the best response. Options A, C, D, and E are not the best responses.

Solution to Question 10
The "peripheral washout" sign has been described as occurring only with malignant tumors [13]. It is thought to occur due to differences in regional vascularity of the tumor as it enlarges—that is, as the tumor increases in size, the central region is relatively ischemic or necrotic compared with the peripheral region. Thus, on delayed contrast-enhanced images, the clearance of contrast material (washout) from the peripheral regions is greater than that in the central regions. The presumed more homogeneous vascularity is thought to explain why this finding is not present in benign tumors. Option E is the best response. Options A, B, C, and D are not the best responses.

Solution to Question 11
Three patterns of enhancement have been described for hemangiomas [14]. The most common pattern is early, peripheral, nodular, interrupted enhancement that progresses in a centripetal fashion on later images, with contrast retention on delayed images. The attenuation or signal should follow the blood pool. Large hemangiomas typically appear similar on earlier images, but may have persistent central hypoattentuation or hypodensity. Small hemangiomas can show early, homogeneous hyperenhancement that persists on delayed images. Option C is the best response. The patterns of enhancement described in the other options are not described in hemangioma. Options A, B, D, and E are not the best responses.

Solution to Question 12
Both hypervascular metastases and hemangiomas typically show T1-weighted hypointensity and marked T2-weighted hyperintensity on unenhanced sequences. In addition, because of the presumed antiangiogenesis effects of chemotherapy, treated metastases can also show early nodular enhancement, as well as delayed contrast retention due to enlarged extracellular spaces or decreased venous drainage [15]. Thus, Options A, B, C, and E are not distinguishing features and are not the best responses. However, because hemangiomas classically exhibit interrupted peripheral nodular enhancement, the finding of an intact, continuous, peripheral rim of nodular enhancement in a patient undergoing chemotherapy should raise suspicion for metastases. Option D is the best response.

References

  1. Davey MS, Cohen MD. Imaging of gastrointestinal malignancy in childhood. Radiol Clin North Am 1996;34 : 717-742[Medline]
  2. Donnelly LF, Bisset GS 3rd. Pediatric hepatic imaging. Radiol Clin North Am 1998;36 : 413-427[CrossRef][Medline]
  3. Kawamoto S, Soyer PA, Fishman EK, Bluemke DA. Nonneoplastic liver disease: evaluation with CT and MR imaging. RadioGraphics 1998;18 : 827-848[Abstract]
  4. Iyer CP, Stanley P, Mahour GH. Hepatic hemangiomas in infants and children: a review of 30 cases. Am Surg1996; 62:356 -360[Medline]
  5. Boon LM, Burrows PE, Paltiel HJ, et al. Hepatic vascular anomalies in infancy: a twenty-seven-year experience. J Pediatr1996; 129:346 -354[CrossRef][Medline]
  6. Kassarjian A, Zurakowski D, Dubois J, Paltiel HJ, Fishman SJ, Burrows PE. Infantile hepatic hemangiomas: clinical and imaging findings and their correlation with therapy. AJR 2004;182 : 785-795[Abstract/Free Full Text]
  7. Dubois J, Garel L. Imaging and therapeutic approach of hemangiomas and vascular malformations in the pediatric age group. Pediatr Radiol 1999; 29:879 -893[CrossRef][Medline]
  8. Bittle MM, Chew FS. Radiological reasoning: incidentally discovered liver mass. AJR 2006;186 [6 suppl 1]:S434 -S441[Abstract/Free Full Text]
  9. Abehsera M, Vilgrain V, Belghiti J, Fléjou JF, Nahum H. Inflammatory pseudotumor of the liver: radiologic–pathologic correlation. J Comput Assist Tomogr 1995;19 : 80-83[Medline]
  10. Venkataraman S, Semelka RC, Braga L, Danet IM, Woosley JT. Inflammatory myofibroblastic tumor of the hepatobiliary system: report of MR imaging appearance in four patients. Radiology2003; 227:758 -763[Abstract/Free Full Text]
  11. Schneider G, Grazioli L, Saini S. MRI of the liver. Milano, MD: Springer, 2003:113 -137
  12. Gisbert JP, Garcia-Buey L, Pajares JM, Moreno-Otero R. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterology2003; 125:1723 -1732[CrossRef][Medline]
  13. Maher MM, McDermott SR, Fenlon HM, et al. Imaging of primary non-Hodgkin's lymphoma of the liver. Clin Radiol2001; 56:295 -301[CrossRef][Medline]
  14. Semelka RC, Brown ED, Ascher SM, et al. Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images. Radiology1994; 192:401 -406[Abstract/Free Full Text]
  15. Semelka RC, Worawattanakul S, Noone TC, et al. Chemotherapy-treated liver metastases mimicking hemangiomas on MR images. Abdom Imaging 1999; 24:378 -382[CrossRef][Medline]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow CME/SAM
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, C.-H.
Right arrow Articles by Beaty, S. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, C.-H.
Right arrow Articles by Beaty, S. D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS